Last updated: February 18, 2024
Sponsor: Tel-Aviv Sourasky Medical Center
Overall Status: Completed
Phase
N/A
Condition
Pain
Treatment
Paracetamol 1000 mg
Ibuprofen 400 mg
Clinical Study ID
NCT04653506
0368-20-TLV
Ages 18-50 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Women between the ages of 18-50, who gave birth in a vaginal birth
Exclusion
Exclusion Criteria:
- Sensitivity to Paracetamol or Ibuprofen
- After cesarean section
- Received analgesia prior to study recruitment
- Perineal tears grade 3 \ 4
- Women with chronic pain, rheumatic disease, fibromyalgia, or trauma
- Women with a diagnosis or medication for anxiety or depression
- Dropout for women whose newborns needed respiratory support with intubation, cooling,prolonged hospitalization in NICU exceeding one week
Study Design
Total Participants: 107
Treatment Group(s): 2
Primary Treatment: Paracetamol 1000 mg
Phase:
Study Start date:
November 28, 2020
Estimated Completion Date:
July 06, 2023
Study Description
Connect with a study center
Tel Aviv Medical Center
Tel Aviv, 6423906
IsraelSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.